CGEN SEC Filings
SEC filings for CGEN. Annual and quarterly reports, 8-K events, Form 4 insider filings and 13D/G stake disclosures.
| Form | Filed | Accession |
|---|---|---|
| 4Levine ZuritSVP, Business Development | Jul 30, 2026 | 0001178913-26-003729EDGAR |
| 4Silberman DavidChief Financial Officer | Jul 30, 2026 | 0001178913-26-003727EDGAR |
| 4Perry Eran | Jul 30, 2026 | 0001178913-26-003721EDGAR |
| 4Kredo Russo SharonSVP, Research & Discovery | Jul 30, 2026 | 0001178913-26-003717EDGAR |
| 4Livnat Savitzky Kinneret | Jul 30, 2026 | 0001178913-26-003715EDGAR |
| 4Hukkelhoven Mathias | Jul 30, 2026 | 0001178913-26-003713EDGAR |
| 4Halevy Gilead | Jul 30, 2026 | 0001178913-26-003711EDGAR |
| 4ZWEIFACH SANFORD S | Jul 30, 2026 | 0001178913-26-003709EDGAR |
| 4Mahler MichelleChief Medical Officer | Jul 30, 2026 | 0001178913-26-003706EDGAR |
| 4Levine ZuritSVP, Business Development | Jul 13, 2026 | 0001178913-26-003472EDGAR |
| 4Levine ZuritSVP, Business Development | Apr 27, 2026 | 0001178913-26-002245EDGAR |
| 4Ophir EranPresident and CEO | Apr 27, 2026 | 0001178913-26-002243EDGAR |
| 4Ophir EranPresident and CEO | Apr 15, 2026 | 0001178913-26-002133EDGAR |
| 4Levine ZuritSVP, Business Development | Apr 15, 2026 | 0001178913-26-002131EDGAR |
| 4/ALevine ZuritSVP, Business Development | Apr 15, 2026 | 0001178913-26-002128EDGAR |
| 4Levine ZuritSVP, Business Development | Apr 9, 2026 | 0001178913-26-002036EDGAR |
| 4Levine ZuritSVP, Business Development | Apr 3, 2026 | 0001178913-26-001990EDGAR |
| 4Ophir EranPresident and CEO | Apr 3, 2026 | 0001178913-26-001988EDGAR |
| 4Levine ZuritSVP, Business Development | Mar 30, 2026 | 0001178913-26-001896EDGAR |
Never miss a CGEN filing.
Get an email when CGEN files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR.